QR Code

Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort

Dolutegravir (DTG) is currently one of the most used Integrase inhibitors (INI) in antiretroviral therapies (ARV) in both naïve and experienced people living with HIV (PLWHIV). We analyzed a multicenter cohort of PLWHIV, both naïve and experienced, starting an ARV including DTG. We enrolled 3775 PLW...

Full description

Saved in:
Main Authors: Arturo Ciccullo, Gianmaria Baldin, Vanni Borghi, Filippo Lagi, Alessandra Latini, Gabriella d’Ettorre, Letizia Oreni, Paolo Fusco, Amedeo Capetti, Massimiliano Fabbiani, Andrea Giacomelli, Alessandro Grimaldi, Giordano Madeddu, Gaetana Sterrantino, Cristina Mussini, Simona Di Giambenedetto
Format: Artigo
Language:Inglês
Published: MDPI AG 2022-01-01
Series:Viruses
Subjects:
HIV
HAART
dolutegravir
toxicity
Online Access:https://www.mdpi.com/1999-4915/14/1/163
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items